3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one

C118H151F6N25O6 — CID 161107372

IUPAC3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one
SMILESO=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(C(F)(F)F)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(C(F)(F)F)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCOC(c2ccccc2)C1
InChIInChI=1S/C26H33N5O.C25H31N5O2.C25H31N5O.2C21H28F3N5O/c32-24(31-17-14-20(15-18-31)19-7-3-1-4-8-19)12-11-22-25-23(30-29-22)13-16-27-26(25)28-21-9-5-2-6-10-21;31-23(30-15-16-32-22(17-30)18-7-3-1-4-8-18)12-11-20-24-21(29-28-20)13-14-26-25(24)27-19-9-5-2-6-10-19;31-23(30-16-14-19(17-30)18-7-3-1-4-8-18)12-11-21-24-22(29-28-21)13-15-26-25(24)27-20-9-5-2-6-10-20;22-21(23,24)14-5-4-12-29(13-14)18(30)9-8-16-19-17(28-27-16)10-11-25-20(19)26-15-6-2-1-3-7-15;22-21(23,24)14-9-12-29(13-10-14)18(30)7-6-16-19-17(28-27-16)8-11-25-20(19)26-15-4-2-1-3-5-15/h1,3-4,7-8,13,16,20-21H,2,5-6,9-12,14-15,17-18H2,(H,27,28)(H,29,30);1,3-4,7-8,13-14,19,22H,2,5-6,9-12,15-17H2,(H,26,27)(H,28,29);1,3-4,7-8,13,15,19-20H,2,5-6,9-12,14,16-17H2,(H,26,27)(H,28,29);10-11,14-15H,1-9,12-13H2,(H,25,26)(H,27,28);8,11,14-15H,1-7,9-10,12-13H2,(H,25,26)(H,27,28)
InChIKeyUJFUSVZBHHOKLI-UHFFFAOYSA-N
MW2129.66 g/mol
LogP22.80
Rot. Bonds28

About 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one

3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one (PubChem CID 161107372) has the molecular formula C118H151F6N25O6 and a molecular weight of 2129.66 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one.

Molecular Properties

Compound Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one
PubChem CID161107372
Molecular FormulaC118H151F6N25O6
Molecular Weight2129.66 g/mol
Exact Mass2128.22
IUPAC Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one
SMILESO=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(C(F)(F)F)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(C(F)(F)F)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCOC(c2ccccc2)C1
InChIInChI=1S/C26H33N5O.C25H31N5O2.C25H31N5O.2C21H28F3N5O/c32-24(31-17-14-20(15-18-31)19-7-3-1-4-8-19)12-11-22-25-23(30-29-22)13-16-27-26(25)28-21-9-5-2-6-10-21;31-23(30-15-16-32-22(17-30)18-7-3-1-4-8-18)12-11-20-24-21(29-28-20)13-14-26-25(24)27-19-9-5-2-6-10-19;31-23(30-16-14-19(17-30)18-7-3-1-4-8-18)12-11-21-24-22(29-28-21)13-15-26-25(24)27-20-9-5-2-6-10-20;22-21(23,24)14-5-4-12-29(13-14)18(30)9-8-16-19-17(28-27-16)10-11-25-20(19)26-15-6-2-1-3-7-15;22-21(23,24)14-9-12-29(13-10-14)18(30)7-6-16-19-17(28-27-16)8-11-25-20(19)26-15-4-2-1-3-5-15/h1,3-4,7-8,13,16,20-21H,2,5-6,9-12,14-15,17-18H2,(H,27,28)(H,29,30);1,3-4,7-8,13-14,19,22H,2,5-6,9-12,15-17H2,(H,26,27)(H,28,29);1,3-4,7-8,13,15,19-20H,2,5-6,9-12,14,16-17H2,(H,26,27)(H,28,29);10-11,14-15H,1-9,12-13H2,(H,25,26)(H,27,28);8,11,14-15H,1-7,9-10,12-13H2,(H,25,26)(H,27,28)
InChIKeyUJFUSVZBHHOKLI-UHFFFAOYSA-N
XLogP22.80
TPSA378.78 Ų
H-Bond Donors10
H-Bond Acceptors21
Rotatable Bonds28
Heavy Atoms155
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002129.66
LogP ≤ 522.80
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1021

Analyze 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one?
The IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one (CID 161107372) is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one.
What is the SMILES notation for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one?
The canonical SMILES for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one is O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(C(F)(F)F)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCC(c2ccccc2)CC1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCCC(C(F)(F)F)C1.O=C(CCc1[nH]nc2ccnc(NC3CCCCC3)c12)N1CCOC(c2ccccc2)C1.
What is the InChIKey of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one?
The InChIKey is UJFUSVZBHHOKLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H33N5O.C25H31N5O2.C25H31N5O.2C21H28F3N5O/c32-24(31-17-14-20(15-18-31)19-7-3-1-4-8-19)12-11-22-25-23(30-29-22)13-16-27-26(25)28-21-9-5-2-6-10-21;31-23(30-15-16-32-22(17-30)18-7-3-1-4-8-18)12-11-20-24-21(29-28-20)13-14-26-25(24)27-19-9-5-2-6-10-19;31-23(30-16-14-19(17-30)18-7-3-1-4-8-18)12-11-21-24-22(29-28-21)13-15-26-25(24)27-20-9-5-2-6-10-20;22-21(23,24)14-5-4-12-29(13-14)18(30)9-8-16-19-17(28-27-16)10-11-25-20(19)26-15-6-2-1-3-7-15;22-21(23,24)14-9-12-29(13-10-14)18(30)7-6-16-19-17(28-27-16)8-11-25-20(19)26-15-4-2-1-3-5-15/h1,3-4,7-8,13,16,20-21H,2,5-6,9-12,14-15,17-18H2,(H,27,28)(H,29,30);1,3-4,7-8,13-14,19,22H,2,5-6,9-12,15-17H2,(H,26,27)(H,28,29);1,3-4,7-8,13,15,19-20H,2,5-6,9-12,14,16-17H2,(H,26,27)(H,28,29);10-11,14-15H,1-9,12-13H2,(H,25,26)(H,27,28);8,11,14-15H,1-7,9-10,12-13H2,(H,25,26)(H,27,28).
What are the key properties of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one?
3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one has a molecular weight of 2129.66 g/mol, XLogP of 22.80, 28 rotatable bonds, 10 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one is sourced from PubChem (CID 161107372), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).